Apixaban vs No Anticoagulation After Anticoagulation-Associated ICH in Patients With Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial
Lancet Neurol 2021 Nov 01;20(11)907-916, FHBM Schreuder, KM van Nieuwenhuizen, J Hofmeijer, SE Vermeer, H Kerkhoff, E Zock, GJ Luijckx, GP Messchendorp, J van Tuijl, HP Bienfait, SJ Booij, IR van den Wijngaard, MJM Remmers, AHCML Schreuder, DW Dippel, J Staals, PJAM Brouwers, MJH Wermer, JM Coutinho, VIH Kwa, IC van Gelder, REG Schutgens, B Zweedijk, A Algra, JW van Dalen, L Jaap Kappelle, GJE Rinkel, HB van der Worp, CJM KlijnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.